GlassScriptPhysician profile
Shankar K Thampi
NPI 1124412457
$45,571.47
in general payments reported to CMS, 2019-2025
19 companies · $1,178 in 2025
The $1,178 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $69.14 · 2021: $597 · 2022: $41K · 2023: $2,042 · 2024: $990 · 2025: $1,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,210.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25,289.90 | 2022-2025 | Corevalve Evolut R, Onyx Frontier |
| Abbott Laboratories | $12,915.35 | 2022-2025 | Diamondback Coronary, Mitraclip, Amplatzer Amulet |
| Osprey Medical INC | $1,250.00 | 2022 | |
| Shockwave Medical, INC | $1,075.51 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $1,055.99 | 2022 | |
| Boston Scientific Corporation | $1,018.25 | 2021-2025 | General - Therapies, Avvigo Guidance System, Stingray |
| Saranas, INC. | $621.68 | 2021-2022 | |
| Philips North America LLC | $495.01 | 2021-2025 | Coronary Other |
| Abiomed | $409.81 | 2022 | |
| Cardiovascular Systems INC. | $389.64 | 2022-2023 | Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $208.98 | 2022-2025 | Lifevest |
| Spectrawave, INC | $199.16 | 2025 | Hypervue Imaging System, Starlight Imaging Catheter |
| Inari Medical, INC. | $101.68 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $82.98 | 2022-2023 | Repatha |
| Terumo Medical Corporation | $61.54 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $44.06 | 2022 | |
| W. L. Gore & Associates, INC. | $42.75 | 2024 | Gore Septal Occluder |
| Astrazeneca Pharmaceuticals LP | $40.71 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $33.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shankar Thampi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.